FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer

author
created [InstanceEdit:2011994] Rothfels, K, 2011-11-22
dbId 2011995
displayName FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer
journal Cancer Res
pages 2085-94
pubMedIdentifier 20179196
schemaClass LiteratureReference
title FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer
url http://www.ncbi.nlm.nih.gov/pubmed/20179196
volume 70
year 2010
Cite Us!